ArticleAnnals of hematology2022

Tirabrutinib maintenance therapy for a patient with high-dose methotrexate-ineligible primary central nervous system lymphoma.

Tadashi Okamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.